Atlas Air Worldwide Reports Fourth-Quarter and Full-Year 2016 Results
Feb 23, 2017 13:01 pm UTC| Business
Record 4Q Revenues, Significant Increase in 4Q Reported Earnings, Record Adjusted 4Q Earnings; Positioned for Earnings Growth in 20174Q16 Reported Income from Continuing Operations of $28.7 Million, $1.12 per Share4Q16...
Atlas Air Worldwide Reports Fourth-Quarter and Full-Year 2016 Results
Feb 23, 2017 13:01 pm UTC| Business
Record 4Q Revenues, Significant Increase in 4Q Reported Earnings, Record Adjusted 4Q Earnings; Positioned for Earnings Growth in 20174Q16 Reported Income from Continuing Operations of $28.7 Million, $1.12 per Share4Q16...
TPC Group Announces Fourth Quarter 2016 Earnings Call
Feb 23, 2017 13:01 pm UTC| Business
HOUSTON, Feb. 23, 2017 -- TPC Group Inc. today announced that it will post its results for the quarter ended December 31, 2016 on its website on Wednesday, March 8 at 1 p.m. EST (noon CST) and that it will host a...
TPC Group Announces Fourth Quarter 2016 Earnings Call
Feb 23, 2017 13:01 pm UTC| Business
HOUSTON, Feb. 23, 2017 -- TPC Group Inc. today announced that it will post its results for the quarter ended December 31, 2016 on its website on Wednesday, March 8 at 1 p.m. EST (noon CST) and that it will host a...
EWTN Kicks Off Its 2017 Spring Season March 1
Feb 23, 2017 13:01 pm UTC| Business
Irondale, AL, Feb. 23, 2017 -- In 1917, during the fourth year of World War I, Our Lady appeared six times to three shepherd children in Fatima, Portugal with prophetic messages and a miracle that stunned the world. In...
EWTN Kicks Off Its 2017 Spring Season March 1
Feb 23, 2017 13:01 pm UTC| Business
Irondale, AL, Feb. 23, 2017 -- In 1917, during the fourth year of World War I, Our Lady appeared six times to three shepherd children in Fatima, Portugal with prophetic messages and a miracle that stunned the world. In...
Chimerix to Announce Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017
Feb 23, 2017 13:00 pm UTC| Business
DURHAM, N.C., Feb. 23, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs,today announced...